Based on the KM-plotter database, we further revealed that GC patients with high ZC3H13 expression had poorer OS, first-progression survival (FPS) and post-progression survival (PPS) (Fig. 1E–G). The gene discussed is ZC3H13; the disease is gastric cancer.